Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
18.38
↑ 358% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
4.02
Historical baseline
PeriodValueYoY Change
202518.38+33.7%
202413.75-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-